Terms and Conditions

TRADEMARK OWNERSHIP: DIPLOMATE OF MEDICAL CANNABINOID SCIENCE

The Institute of Cannabinoid Medicine (TIOCM) owns the trademark name of, “DIPLOMATE OF MEDICAL CANNABINOID SCIENCE” with USPTO Serial Number:  90041261. Goods and  Services: IC 041. US 100 101 107. G & S: Education services, namely,  providing classes in the field of science. 

File Date USPTO: July 8, 2020

Non-Discrimination Policy 

The Institute of Cannabinoid Medicine (TIOCM) is non-sectarian and does not discriminate with regard  to race, creed, religion, color, national origin, age, gender, disability, marital status, or any other legally  protected status or other protected class in any of its academic course activities, employment practices, or  admissions policies.

Family Educational Rights and Privacy Act 

All students enrolled at The Institute of Cannabinoid Medicine (TIOCM) shall have the right to inspect  and review their educational records, to request corrections and deletions, and to limit disclosure with the  Family Educational Rights and Privacy Act of 1974.     

Accommodations Under the Americans with Disabilities Act (ADA) 

The Institute of Cannabinoid Medicine (TIOCM) complies with all requirements of the Americans with  Disabilities Act (ADA) and other applicable federal and state laws. The Institute of Cannabinoid  Medicine (TIOCM) aims to provide an equitable testing opportunity for candidates to demonstrate the  knowledge and skill measured by the examination. As such, The Institute of Cannabinoid Medicine  (TIOCM) will accommodate reasonable accommodation requests for those with a documented disability. Appropriate documentation, such as an official, signed letter from a licensed healthcare provider  confirming the disability and recommending a specific, reasonable accommodation, must be submitted  with the request. The Institute of Cannabinoid Medicine (TIOCM) treats this information with strict  confidentiality and it will not be shared with any source, without candidate’s express written permission. For those requesting assistance by request can email info@tiocm.org                                 

Academic Integrity Policy 

The Institute of Cannabinoid Medicine (TIOCM) has a zero tolerance policy. Integrity is a foundational  concept of professional behavior and The Institute of Cannabinoid Medicine (TIOCM) takes such matters  very seriously. In general, if you have to ask if behavior would violate the integrity policy, it probably  does. The Institute of Cannabinoid Medicine (TIOCM) is committed to educate, implement, support, and  enforce sound academic and professional integrity. Collaboration Defined · Working together on assignments and projects · Citing literature Cheating Defined · Not doing the work · Not doing the work and directly copying If academic dishonesty is suspected, the information will be documented and brought before The Institute  of Cannabinoid Medicine (TIOCM) for review. The student or students will be notified that there is a  suspicion of academic dishonesty and an investigation will follow. Information retrieved during the  investigation process will be evaluated and the student or students involved will be informed of the result.  In the event that academic dishonesty is validated during the investigation process, the individual or  individuals involved will be notified of any action The Institute of Cannabinoid Medicine (TIOCM)  chooses to take.

Appropriate Use Policy for IT (Information Technology) Resources 

The Institute of Cannabinoid Medicine (TIOCM) provides an information technology (IT) environment  that includes access to an online learning (LMS) platform with secure username/password access for  faculty, staff, and students, computing services, wireless internet, treatment planning software, remote  The Institute of Cannabinoid Medicine Page: 22 access to treatment planning software on campus, online databases, and other course resources. These  resources (“IT resources” or “resources”) are intended to support the operations of the The Institute of  Cannabinoid Medicine (TIOCM).

Appropriate Use for IT (Information Technology) 

Resources are provided for learning-related purposes including support for instruction, research,  administrative functions, and student use for the purpose of facilitating the successful completion of  coursework. Use of the resources should be limited to these purposes, including incidental personal use.  Incidental personal use must not interfere with the intended use of the IT resources or include any illegal  activity. Incidental personal use by staff members must not interfere with the fulfillment of job  responsibilities or disrupt the work environment.

User Responsibilities 

Users are responsible for being aware of any The Institute of Cannabinoid Medicine (TIOCM) policies or  regulations that govern the use of IT resources. Users must comply with all federal and state laws and The  Institute of Cannabinoid Medicine (TIOCM) policies. Users may not engage in unauthorized use of  resources, regardless of whether the resource is protected against unauthorized use.

Security 

The Institute of Cannabinoid Medicine (TIOCM) may, without further notice to Users, take any action it  deems necessary to protect the interests of the The Institute of Cannabinoid Medicine (TIOCM) and to  maintain the stability, security, and operational effectiveness of IT resources. This may include, but is not  limited to, scanning stored data, network traffic, usage patterns, and other uses of IT resources.

Privacy 

Responsible parties of the IT environment will perform management tasks in a manner that is respectful  to individual Users. This includes, but is not limited to, monitoring and routine system maintenance  including the backup of data, monitoring of general use patterns, and other usage activities The Institute  of Cannabinoid Medicine (TIOCM) may use security tools and network and systems monitoring hardware  and software without notice.

Grievance Policy 

First Step-Anyone with a grievance or complaint may request an individual conference with the instructor  or staff member to discuss the matter. Second Step-If a satisfactory resolution to the problem is not reached, the aggrieved party should seek  guidance from the Director. Third Step-If the grievance is not resolved within 5 days of the incident, the aggrieved party must present  to the President of The Institute of Cannabinoid Medicine (TIOCM) in writing, all facts of the grievance. Within 48 hours, upon receipt of the written information, the President will schedule a Grievance  Committee hearing. The time of the meeting will be communicated in writing to all parties. The  committee will consist of the Vice President and other The Institute of Cannabinoid Medicine (TIOCM)  leadership/officers not involved with the incident in question. All Persons or their representatives  involved with the incident must be present via teleconference at the time of the hearing. All parties  involved will be given the opportunity to discuss the grievance. The Grievance Committee will excuse all  parties involved in the grievance and immediately review and conclude the case. The decision of the  committee will be communicated to those involved in the incident within 48 hours. The committee  decision will be final.

Anti-Hazing and Bullying Policy 

The Institute of Cannabinoid Medicine (TIOCM) is dedicated to promoting a safe and healthy campus  environment for its students, faculty, staff and visitors. In addition, The Institute of Cannabinoid  The Institute of Cannabinoid Medicine Page: 23 Medicine (TIOCM) is committed to promoting an environment that fosters respect for the dignity and  rights of all its community members. As such, The Institute of Cannabinoid Medicine (TIOCM) will not  tolerate hazing activities or bullying by any individuals, groups, or recognized student organizations.

Sexual Harassment Policy 

In an effort to provide a safe and productive educational and working environment for students, faculty,  and staff, The Institute of Cannabinoid Medicine (TIOCM) has adopted the following policy to promote  an environment free of sex and gender discrimination, sexual harassment, sexual assault, sexual  misconduct, interpersonal violence (including domestic violence and dating violence), and stalking.  Gender discrimination includes discrimination on the basis of gender orientation, gender identity, or  gender expression.

Sexual Harassment Policy-Reporting to Authorities 

The Institute of Cannabinoid Medicine (TIOCM) prohibits discrimination on the basis of sex and gender  and prohibits sexual harassment, sexual assault, sexual misconduct, interpersonal violence, stalking,  physical abuse, threats of violence, physical assault, or any form of sexual violence. These behaviors are  hereafter referred to as prohibited conduct. Individuals who participate or attempt to participate in  prohibited conduct are subject to disciplinary action by The Institute of Cannabinoid Medicine (TIOCM), regardless of any action that may be taken by civil or criminal authorities.

Drug and Alcohol Abuse Prevention Program and Policy 

The Institute of Cannabinoid Medicine (TIOCM) is committed to provide students, faculty, staff and  visitors with a safe and healthful learning environment and workplace. It is the policy of the school that  illicit drugs and alcohol use, manufacture, unlawful possession, sale, distribution, or dispensation by any  student or employee on The Institute of Cannabinoid Medicine (TIOCM) property or virtual learning  platform (LMS) or as part of any The Institute of Cannabinoid Medicine (TIOCM) activities is strictly  prohibited.

Dismissal 

The Institute of Cannabinoid Medicine (TIOCM). reserves the right to dismiss any student from the  program for any of the following reasons: · Non-compliance of the rules and regulations of The Institute of Cannabinoid Medicine (TIOCM) · Engagement in any illegal or criminal act · Any conduct that brings discredit or embarrassment to The Institute of Cannabinoid Medicine (TIOCM) · Failure to make satisfactory academic progress · Failure to satisfy financial obligations to The Institute of Cannabinoid Medicine (TIOCM).

Sanctions and Revocation of Diplomate 

The sanction imposed upon an individual whom The Institute of Cannabinoid Medicine (TIOCM) has  determined to have violated the policies and rules of its certification program must reasonably relate to  the nature and severity of the violation, focusing on reformation of the conduct of the member and  deterrence of similar conduct by others. Any of the following sanctions may be imposed by the Executive  Board upon an individual: 1. Written reprimand; 2. Suspension of the certificant for a designated period; or 3. Suspension of applicant’s ability to submit an application for certification/examination; or 4. Termination of the individual’s certification; or 5. Termination of the individual’s certification application status including prohibiting the individual from applying for certification in the future.

Resignation of Diplomate 

If an individual who is the subject of a complaint voluntarily surrenders his or her certification (or in the  case of an applicant, surrenders his or her ability to apply for certification in the future) at any time during  the pendency of a complaint under these Procedures, the complaint is dismissed without any further  action by The Institute of Cannabinoid Medicine (TIOCM). The entire record is sealed and the individual  may not reapply for certification. However, The Institute of Cannabinoid Medicine (TIOCM) may  authorize the President to communicate the fact and date of resignation, and the fact and general nature of  the complaint which was pending at the time of the resignation, to or at the request of a government entity  engaged in the administration of law. Similarly, in the event of such resignation, the certificant's employer  (if deemed appropriate by The Institute of Cannabinoid Medicine (TIOCM)) and the person or entity who  submitted the complaint are notified of the fact and date of resignation and that The Institute of  Cannabinoid Medicine (TIOCM) has dismissed the complaint as a result. 

OPERATIONS 

The Institute of Cannabinoid Medicine (TIOCM) operates from within the United States of America,  within the State of Indiana, the City of South Bend and County of St. Joseph.

TERMS OF USE 

The Institute of Cannabinoid Medicine (TIOCM) (“TIOCM,” “we,” or “our”) operates various websites  and applications (collectively the “Site”) with links to these Terms of Use. By accessing and using the  Site, you agree to be bound by these Terms of Use and all other policies that appear on the Site. If you do  not wish to be bound by these Terms of Use, you may not use the Site.

DISCLAIMER 

The information contained in these topics is not intended nor implied to be a substitute for professional  medical advice, it is provided for educational purposes only. You assume full responsibility for how you  choose to use this information. Always seek the advice of your physician or other qualified healthcare  provider before starting any new treatment or discontinuing an existing treatment. Talk with  your healthcare provider about any questions you may have regarding a medical condition. Nothing  contained in these topics is intended to be used for medical diagnosis or treatment.

LIABILITY DISCLAIMER: WITH AND WITHOUT NOTICE 

The information, software, products and services included in or available through the site may include  inaccuracies and or typographical errors. The Institute of Cannabinoid Medicine (TIOCM) may make improvements or changes to the site at any time with and without notice.

INDEMNIFICATION AND HOLD HARMLESS 

You agree to indemnify, defend, and hold harmless The Institute of Cannabinoid Medicine (TIOCM), its  officers, directors, employees, agents, and third parties for any losses, costs, liabilities, and  expenses (including reasonable attorneys’ fees) relating to or arising out of your use of or inability to use  the Site, any Submission made by you, your violation of any Terms of Use, your violation of any rights  of a third party, or your violation of any applicable laws or restrictions. The Institute of Cannabinoid  Medicine (TIOCM) reserves the right, at its own cost, to assume the exclusive defense and control of any  matter otherwise ubject to indemnification by you, in which event you will fully cooperate with The  Institute of Cannabinoid Medicine (TIOCM) in asserting any available defenses.

LEGAL ADVICE  

The legal information on the Site is not intended to be a substitute for professional legal advice. If you  need legal advice for your specific problem, you should consult a licensed attorney in your area.

PRIVACY 

Your use of the Site is subject to The Institute of Cannabinoid Medicine (TIOCM) Privacy Policy, which  also governs the Site and informs users of our data collection practices.

ELECTRONIC COMMUNICATIONS 

Visiting The Institute of Cannabinoid Medicine (TIOCM) Site and sending emails to The Institute of  Cannabinoid Medicine (TIOCM) constitute electronic communications. By posting any user-generated  content to the Site, you consent to receive electronic communications and you agree that all agreements,  notices, disclosures and other communications that we provide to you electronically, via email, and on  the Site satisfy any legal requirement that such communications be in writing to The Institute of  Cannabinoid Medicine (TIOCM) at info@tiocm.org 

ACCOUNT INFORMATION 

If you create an account to use The Institute of Cannabinoid Medicine (TIOCM) Site, including any  forum associated with the Site, you are responsible for maintaining the confidentiality of your account  and password and for restricting access to your computer, and you agree to accept responsibility for all  activities that occur under your account or password. You may not assign or otherwise transfer your  account to any other person or entity. 

ACCOUNT INFORMATION THIRD PARTY 

You acknowledge that The Institute of Cannabinoid Medicine (TIOCM) is not responsible for third party  access to your account that results from theft or misappropriation of your account. The Institute of  Cannabinoid Medicine (TIOCM) reserves the right to refuse or cancel service, terminate accounts,  or remove or edit content at any time in The Institute of Cannabinoid Medicine (TIOCM) sole  discretion.

ACCOUNT INFORMATION: INTERNATIONAL USERS 

The Institute of Cannabinoid Medicine (TIOCM) Site is controlled, operated, and administered by The  Institute of Cannabinoid Medicine (TIOCM) from within the United States of America, within the State of Indiana, the City of South Bend and County of St. Joseph. If you access the Site from elsewhere, you  are responsible for compliance with all local and international laws. You agree that you will not use  content accessed on the Site in any country or in any manner prohibited by any applicable laws  or restrictions.

NON COLLECTION OF INFORMATION OF PERSONS UNDER THE AGE OF 18 

The Institute of Cannabinoid Medicine (TIOCM) does not knowingly collect, either online or offline,  personal information from persons under the age of eighteen (18). If you are under eighteen (18), you are  not permitted to use and or access or collect information from The Institute of Cannabinoid Medicine  (TIOCM).

THIRD PARTY SITES AND AFFILIATES 

The Site may contain links to other websites (“Linked Sites”). The Linked Sites are not under the control  of The Institute of Cannabinoid Medicine (TIOCM), and The Institute of Cannabinoid Medicine  (TIOCM) is not responsible for any Linked Site’s content, including without limitation any link  contained in a Linked Site or any changes to a Linked Site. The Institute of Cannabinoid Medicine  (TIOCM) provides such links only as a convenience.

THIRD PARTY SITES AND AFFILIATES AND PRODUCTS, SERVICES, DOMAINS 

Certain services made available via the Site are delivered by third party sites. By using any product,  service, or functionality originating from the Site domain, you hereby acknowledge and consent that The  Institute of Cannabinoid Medicine (TIOCM) may share such information and data with any third party  with The Institute of Cannabinoid Medicine (TIOCM) has a contractual relationship to provide the  requested product, service, or functionality on behalf of Site users.

NO UNLAWFUL OR PROHIBITED USE OF INTELLECTUAL PROPERTY: PART 1 

You are granted a non-exclusive, non-transferable, revocable license to access and use the Site strictly in  accordance with these Terms of Use. As a condition of your use of the Site, you warrant to The Institute  of Cannabinoid Medicine (TIOCM) that you will not use the Site for any purpose that is unlawful or  prohibited by these Terms of Use. You may not use the Site in any manner that could damage, disable,  overburden, or impair the Site or interfere with any other party’s use and enjoyment of the Site. You may  not obtain or attempt to obtain any materials or information through any means not intentionally made  available or provided for through the Site.

NO UNLAWFUL OR PROHIBITED USE OF INTELLECTUAL PROPERTY: PART 2 

All content included as part of the Site, such as text, graphics, logos, images, any compilation thereof, and  any software used on the Site, is owned, controlled, or licensed by The Institute of Cannabinoid Medicine  (TIOCM) and protected by copyright and other laws that protect intellectual property and proprietary  rights. You agree to observe and abide by all copyright and other proprietary notices, legends, or other  restrictions contained in any such content and will not make any changes thereto. 

The Institute of Cannabinoid Medicine (TIOCM) online learning management (LMS) system software is  operated by Tovuti LMS.

TOVUTI WEBSITE

https://www.tovutilms.com/

PUBLIC NOTICE OF THIRD PARTY LMS PLATFORM TOVUTI: SECURITY https://www.tovutilms.com/security

PUBLIC NOTICE OF THIRD PARTY LMS PLATFORM TOVUTI: HIPAA COMPLIANCE https://www.tovutilms.com/hipaa

PUBLIC NOTICE OF THIRD PARTY LMS PLATFORM TOVUTI: VPAT https://www.tovutilms.com/vpat20

PUBLIC NOTICE OF THIRD PARTY LMS PLATFORM TOVUTI: LOGO AND BRAND  TYPEMARK https://www.tovutilms.com/public-brand-guidelines